Progvin-M Tablet ER

Overview Progvin-M Tablet ER

Diabetic patients with type 2 mellitus may find relief with the extended-release formulation of DuoControl tablets. This dual-action medication effectively manages elevated blood glucose, thereby minimizing the risk of severe diabetic complications and contributing to cardiovascular health. DuoControl tablets are best taken with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should never be altered without their explicit approval; discontinuation may lead to dangerously high blood sugar, potentially resulting in kidney failure or vision loss. This medication is just one element of a comprehensive diabetes management plan, which should incorporate a doctor-recommended diet, regular physical activity, and weight management. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration. Increased fluid intake is advised. Genital fungal infections are a possibility; diligent hygiene practices can help mitigate this risk. Prior to initiating treatment, disclose any pre-existing conditions such as kidney or liver impairment, urinary tract infections, or diuretic use to your healthcare provider. Pregnant or lactating individuals should seek medical counsel before using DuoControl. Limit alcohol consumption as it could exacerbate side effects. Regular blood glucose monitoring is essential during treatment.

Uses of Progvin-M Tablet ER

Managing type 2 diabetes

Major Benefits of Progvin-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Progvin-M Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume Progvin-M ER with a meal.

Common Side effects of Progvin-M Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Progvin-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Progvin-M Extended-Release Tablet with a meal.

How Progvin-M Tablet ER works:

Progvin-M Extended-Release tablets combine dapagliflozin and metformin, two anti-diabetic agents. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action contributes to superior glycemic management.

What if you forget to take Progvin-M Tablet ER :

Should you forget a Progvin-M Tablet ER dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.